Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia
about
How I treat acquired aplastic anemiaManagement of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantationLate Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Inherited Bone Marrow Failure Syndromes (IBMFS): Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on LaCurrent Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium InternatiThe Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell TransplantaNCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediaLate effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant researchEvolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.Anemia of Central Origin.Success of allogeneic marrow transplantation for children with severe aplastic anaemia.Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.Acquired aplastic anemia in children.Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.How I manage aplastic anaemia in children.Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases.Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.Subclinical left ventricular dysfunction in children after hematopoietic stem cell transplantation for severe aplastic anemia: a case control study using speckle tracking echocardiographyAlternative donor HSCT in refractory acquired aplastic anemia - prevention of graft rejection and graft versus host disease by immunoablative conditioning and graft manipulation.Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases.Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up.Long-term risk of cancer development in adult patients with idiopathic aplastic anemia after treatment with anti-thymocyte globulinRisk factors for short term thyroid dysfunction after hematopoietic stem cell transplantation in children.Lung transplantation in children following bone marrow transplantation: a multi-center experience.Gonadal function in patients with severe aplastic anaemia and refractory cytopenia of childhood who undergo bone marrow transplantation after receiving 3-Gy total body irradiation and high-dose cyclophosphamide.Less could be better: the case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.Occupational status among adult survivors following allogeneic stem cell transplantation in childhood.Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.Adult testicular volume predicts spermatogenetic recovery after allogeneic HSCT in childhood and adolescence.Matched related donor hematopoietic stem cell transplantation results in a long-term follow-up of a pediatric acquired severe aplastic anemia subset: A stem cell source perspective.Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment
P2860
Q24617687-2DF31C91-FAE5-488C-AFF2-C9C05DB25F99Q26827226-B14661F7-EC98-43DA-830D-374C0479B133Q30234389-D0782633-EBE9-4D04-B35F-3C66B2711DAFQ30238875-8807DAA9-032C-490C-83FC-24A4AAAA9B16Q30244617-C1F23FA0-A806-4ACD-8D6D-694841E996FDQ35563274-FDB23456-20E9-423E-83D7-05A2315AB57EQ35762578-814AA72D-C754-478F-92BB-3270B5FDF5AAQ36395151-395F91B5-FF22-48E3-9EBD-CF8B18E299D9Q36497220-91AE78AC-EA48-4BF8-AD4A-144AE2205E61Q36784115-679A4DFB-694E-428F-B85C-52D1CB0E4F6EQ36958013-835E2569-CB4E-4506-9372-075F0B8FE612Q37143051-528076AD-0ADA-4012-A317-18B1AEB8DAAEQ37490754-6A92215F-7EFC-42E9-852A-8CCC73635EEAQ37580829-A2B0A07A-EBAD-41C8-A070-5C1DF6920164Q37986162-BD218038-A91A-4EFE-A54F-658EA0792358Q37995011-20B1ED51-C2A5-4CDF-A9F0-71F1C47BEEF6Q38103184-FFC75971-55DB-4B76-8883-4E10427FFA23Q38414472-B1F50D90-0DAB-404F-B9BD-760E4FD614EEQ40028514-A60E25BD-1CBA-4C3D-A077-D45E809F6F54Q40564886-FE008EB8-BAA8-4461-AE37-30810787FD61Q41179462-47202904-AA8A-4F6F-86A7-AFD266BB1DA1Q42368331-BE9C6668-88B9-480B-8314-CA383D512857Q42805890-CAB10422-BE2B-41EC-8E06-5D543911C2D8Q43493827-77D0A0B5-B38F-4AC1-88DE-6B57A9FEED96Q43525271-8E07C045-39CC-4D06-BC01-5E95AE9DBD46Q43928679-CF6E1D63-3DA5-412D-8E33-7F2DD10C3175Q47189367-FECDAAB8-49CB-44C2-BEEB-AB25A0B320ADQ47865904-0ADA759E-2972-46BE-A802-14376060113DQ50580998-F3B3F040-59EC-40E6-9FE3-54F300B3CEACQ50682225-9FC1A097-C161-4EEC-82C9-655D3ACEED5DQ53561431-6C720776-1E55-4FD5-B866-5604AA23A6FFQ58782280-9294B2CC-BE14-45C1-9A90-72437675311B
P2860
Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Late effects among pediatric p ...... ion for severe aplastic anemia
@ast
Late effects among pediatric p ...... ion for severe aplastic anemia
@en
type
label
Late effects among pediatric p ...... ion for severe aplastic anemia
@ast
Late effects among pediatric p ...... ion for severe aplastic anemia
@en
prefLabel
Late effects among pediatric p ...... ion for severe aplastic anemia
@ast
Late effects among pediatric p ...... ion for severe aplastic anemia
@en
P2093
P2860
P50
P1433
P1476
Late effects among pediatric p ...... ion for severe aplastic anemia
@en
P2093
Ann E Woolfrey
Jean E Sanders
Mary E D Flowers
Paul A Carpenter
Paul A Hoffmeister
P2860
P304
P356
10.1182/BLOOD-2011-02-334953
P407
P577
2011-06-07T00:00:00Z